News | March 30, 2009

GE, Archimedes to Collaborate on Coronary Heart Disease Screening Study

March 30, 2009 - GE Healthcare and Archimedes Inc., an independent Healthcare Modeling organization, announced at ACC that they will collaborate to launch a new virtual study to identify an enhanced diagnostic protocol for predicting coronary heart disease (CHD).

The virtual study applies a sophisticated computer model which simulates diagnostic methods for screening and predicting heart disease to help researchers better understand earlier treatments for the number one killer among men and women in the U.S.

Claudio Marelli, M.D., F.A.C.C., strategic medical leader for GE Healthcare said, “The Framingham score fails to predict 25 percent of coronary artery disease. Unconditional treatment might expose patients to unbeneficial treatments. Our collaboration with Archimedes will shed light on the cost-benefit of screening strategies for CHD - and on the value of imaging - to increase current risk stratification capacities to adjust the intensity of treatment accordingly.”

Despite recent progress in the screening and prevention of CHD, many people continue to be improperly identified through current risk measurement tools such as the Framingham Risk Score. The collaboration will allow for the evaluation of screening strategies to determine the potential of an improved model for calculating the risk of CHD based on new technologies and risk factors.

“Leading innovators like GE Healthcare are embracing healthcare modeling,” said Barbara Peskin, principal investigator for Archimedes. “We are delighted to partner with GE Healthcare in its commitment to investigating preventive health through the use of the Archimedes Model.”

For more information: www.gehealthcare.com and www.archimedes.com

Related Content

Coreline Soft Introduces AI Lung Segmentation Solution at RSNA 2018
News | Lung Cancer | December 10, 2018
December 10, 2018 — Korean image software company Coreline Soft Co. Ltd.
FDA Approves New Features for Planmed Verity Cone Beam CT Scanner
Technology | Computed Tomography (CT) | December 07, 2018
The U.S. Food and Drug Administration (FDA) issued an approval letter for the new features and intended uses of the...
Hitachi Medical Systems Europe Introduces Third-Generation Intelligent Vector Flow Mapping
News | Cardiovascular Ultrasound | December 07, 2018
Hitachi Medical Systems Europe introduced what it calls the next level of intelligent Vector Flow Mapping (iVFM) at...
YITU Releases AI-Based Cancer Screening Solutions at RSNA 2018
News | Artificial Intelligence | December 06, 2018
Chinese artificial intelligence (AI) healthcare company YITU healthcare released two brand-new products, Intelligent...
Guerbet Launches Multi-Use OptiVantage Contrast Media Injector in Europe
Technology | Contrast Media Injectors | December 05, 2018
Contrast agent company Guerbet recently announced that the OptiVantage multi-use contrast media injector is now CE...
GE Healthcare Unveils New Applications and Smart Devices Built on Edison Platform
Technology | Artificial Intelligence | December 05, 2018
GE Healthcare recently announced new applications and smart devices built on Edison – a platform that helps accelerate...
Infervision Introduces AI Capabilities for Chest CT Reading
Technology | Computer-Aided Detection Software | November 30, 2018
Big data and artificial intelligence (AI) company Infervision announced the launch of InferRead CT Chest, a new product...
NeuroLogica and MaxQ AI Announce Distribution Agreement
News | Stroke | November 30, 2018
Clinical diagnostics intelligence platform company MaxQ AI and Samsung NeuroLogica announced a distribution agreement...
Videos | Advanced Visualization | November 30, 2018
This is an example of the FDA-cleared OpenSight augmented reality (AR) system for surgical planning from NovaRad at t